Projects per year
Fingerprint
Dive into the research topics where Jonathan M Ducore is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 2 Finished
Research Output
-
Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial
Santagostino, E., Lalezari, S., Reding, M. T., Ducore, J., Ng, H. J., Poulsen, L. H., Michaels, L. A. & Linardi, C. C. G., Nov 1 2019, In : Thrombosis research. 183, p. 13-19 7 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A novel approach to immune tolerance induction in haemophilia A with factor VIII inhibitor
Thornburg, C. D. & Ducore, J. M., Jan 1 2018, (Accepted/In press) In : Haemophilia.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study
Liesner, R. J., Abashidze, M., Aleinikova, O., Altisent, C., Belletrutti, M. J., Borel-Derlon, A., Carcao, M., Chambost, H., Chan, A. K. C., Dubey, L., Ducore, J. M., Fouzia, N. A., Gattens, M., Gruel, Y., Guillet, B., Kavardakova, N., El Khorassani, M., Klukowska, A., Lambert, T., Lohade, S. & 10 others, , Mar 1 2018, In : Haemophilia. 24, 2, p. 211-220 10 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
Hemophilia B gene therapy with a high-specific-activity factor IX variant
George, L. A., Sullivan, S. K., Giermasz, A., Rasko, J. E. J., Samelson-Jones, B. J., Ducore, J. M., Cuker, A., Sullivan, L. M., Majumdar, S., Teitel, J., McGuinn, C. E., Ragni, M. V., Luk, A. Y., Hui, D., Wright, J. F., Chen, Y., Liu, Y., Wachtel, K., Winters, A., Tiefenbacher, S. & 8 others, , Dec 7 2017, In : New England Journal of Medicine. 377, 23, p. 2215-2227 13 p.Research output: Contribution to journal › Article › peer-review
231 Scopus citations -
PERSEPT 1: A phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding
Wang, M., Lawrence, J. B., Quon, D. V., Ducore, J. M., Simpson, M. L., Boggio, L. N., Mitchell, I. S., Yuan, G., Alexander, W. A. & Schved, J. F., 2017, (Accepted/In press) In : Haemophilia.Research output: Contribution to journal › Article › peer-review
7 Scopus citations